Gyre Therapeutics
GYRE
GYRE
46 hedge funds and large institutions have $47M invested in Gyre Therapeutics in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
9% less capital invested
Capital invested by funds: $51.4M → $47M (-$4.42M)
Holders
46
Holding in Top 10
3
Calls
$492K
Puts
$445K
Top Buyers
| 1 | +$6.05M | |
| 2 | +$3.11M | |
| 3 | +$1.66M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.64M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$1.43M |
Top Sellers
| 1 | -$4.65M | |
| 2 | -$855K | |
| 3 | -$422K | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$290K |
| 5 |
FM
Fondren Management
Houston,
Texas
|
-$272K |